SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Pharmova - Quaterly Results

23 May 2026 Evaluate
The March 2026 quarter revenue stood at Rs. 703.00 millions, up 15.82% as compared to Rs. 607.00 millions during the corresponding quarter last year.The company almost doubled its revenue to Rs. 572.00 millions  from Rs. 9.00 millions in the quarter ended March 2026.Operating profit surged to 150.00 millions from the corresponding previous quarter of 112.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 703.00 607.00 15.82 2635.00 2314.00 13.87 2635.00 2314.00 13.87
Other Income 5.00 3.00 66.67 24.00 202.00 -88.12 24.00 202.00 -88.12
PBIDT 150.00 112.00 33.93 512.00 609.00 -15.93 512.00 609.00 -15.93
Interest 9.00 31.00 -70.97 73.00 129.00 -43.41 73.00 129.00 -43.41
PBDT 54.00 81.00 -33.33 352.00 480.00 -26.67 352.00 480.00 -26.67
Depreciation 13.00 15.00 -13.33 60.00 66.00 -9.09 60.00 66.00 -9.09
PBT 41.00 66.00 -37.88 292.00 414.00 -29.47 292.00 414.00 -29.47
TAX -531.00 57.00 -1031.58 93.00 192.00 -51.56 93.00 192.00 -51.56
Deferred Tax -533.00 7.00 -7714.29 47.00 -13.00 -461.54 47.00 -13.00 -461.54
PAT 572.00 9.00 6255.56 199.00 222.00 -10.36 199.00 222.00 -10.36
Equity 159.00 159.00 0.00 159.00 159.00 0.00 159.00 159.00 0.00
PBIDTM(%) 21.34 18.45 15.64 19.43 26.32 -26.17 19.43 26.32 -26.17

Jubilant Pharmova Share Price

973.45 3.70 (0.38%)
05-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.55
Dr. Reddys Lab 1277.80
Cipla 1400.70
Zydus Lifesciences 1088.90
Lupin 2268.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×